Causes and Treatment Outcomes of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in 82 Adult Patients
Hye-In Kim, Shin-Woo Kim, Ga-Young Park, Eu-Gene Kwon, Hyo-Hoon Kim, Ju-Young Jeong, Hyun-Ha Chang, Jong-Myung Lee, Neung-Su Kim
Korean J Intern Med. 2012;27(2):203-210.   Published online 2012 May 31     DOI: https://doi.org/10.3904/kjim.2012.27.2.203
Citations to this article as recorded by Crossref logo
A Retrospective Cohort Study of the Management and Outcomes of Children Hospitalized with Stevens-Johnson Syndrome or Toxic Epidermal Necrolysis
James W. Antoon, Jennifer L. Goldman, Samir S. Shah, Brian Lee
The Journal of Allergy and Clinical Immunology: In.2019; 7(1): 244.     CrossRef
A Case Report—Stevens-Johnson Syndrome as an Adverse Effect of Capecitabine
Priyanka Jadhav, Jane E. Rogers, Rachna Shroff
Journal of Gastrointestinal Cancer.2018; 49(3): 349.     CrossRef
Chronic ocular complications of Stevens-Johnson syndrome associated with causative medications in Korea
Hyo Kyung Lee, Kyung Chul Yoon, Kyoung Yul Seo, Mayumi Ueta, Mee Kum Kim
The Journal of Allergy and Clinical Immunology: In.2018; 6(2): 700.     CrossRef
Current Perspectives on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
Marianne Lerch, Carlo Mainetti, Benedetta Terziroli Beretta-Piccoli, Thomas Harr
Clinical Reviews in Allergy & Immunology.2018; 54(1): 147.     CrossRef
The Epidemiology of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in China
Shang-Chen Yang, Sindy Hu, Sheng-Zheng Zhang, Jin-wen Huang, Jing Zhang, Chao Ji, Bo Cheng
Journal of Immunology Research.2018; 2018: 1.     CrossRef
Clinical Features and Treatment Outcomes among Children with Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A 20-Year Study in a Tertiary Referral Hospital
Susheera Chatproedprai, Vanvara Wutticharoenwong, Therdpong Tempark, Siriwan Wananukul
Dermatology Research and Practice.2018; 2018: 1.     CrossRef
Toxic epidermal necrolysis data from the CELESTE multinational registry. Part I: Epidemiology and general microbiological characteristics
B. Lipový, J. Holoubek, M. Hanslianová, M. Cvanová, L. Klein, I. Grossová, R. Zajíček, P. Bukovčan, J. Koller, M. Baran, P. Lengyel, L. Eimer, M. Jandová, M. Košťál, P. Brychta
Burns.2018; 44(6): 1551.     CrossRef
DILI Associated with Skin Reactions
Sahand Rahnama-Moghadam, Hans L. Tillmann
Current Hepatology Reports.2018; 17(3): 225.     CrossRef
Experience of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in a Regional Hospital: 70 Cases in 7 Years
Jaechun Lee, Jae Wang Kim
The Korean Journal of Medicine.2017; 92(2): 171.     CrossRef
Retrospective Analysis of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in 88 Chinese Patients
Li Wang, Xue-Ling Mei
Chinese Medical Journal.2017; 130(9): 1062.     CrossRef
Stevens-Johnson syndrome and toxic epidermal necrolysis in Dr. Hasan Sadikin General Hospital Bandung, Indonesia from 2009-2013
Oki Suwarsa, Wulan Yuwita, Hartati Purbo Dharmadji, Endang Sutedja
Asia Pacific Allergy.2016; 6(1): 43.     CrossRef
Morbidity and Mortality of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in United States Adults
Derek Y. Hsu, Joaquin Brieva, Nanette B. Silverberg, Jonathan I. Silverberg
Journal of Investigative Dermatology.2016; 136(7): 1387.     CrossRef
Recurrent Toxic Epidermal Necrolysis Syndrome: A Report of Two Cases
Claudia Reynoso-von Drateln, Noemí Gómez-Hernández, Norma Rodríguez-Martínez, Carlos Torres-Lozano
Drug Safety - Case Reports.2016;[Epub]     CrossRef
The Role of Systemic Immunomodulatory Treatment and Prognostic Factors on Chronic Ocular Complications in Stevens–Johnson Syndrome
Dong Hyun Kim, Kyung Chul Yoon, Kyoung Yul Seo, Hyo Seok Lee, Sang Chul Yoon, Chie Sotozono, Mayumi Ueta, Mee Kum Kim
Ophthalmology.2015; 122(2): 254.     CrossRef
Clinical features of and genetic predisposition to drug-induced Stevens–Johnson syndrome and toxic epidermal necrolysis in a single Korean tertiary institution patients—investigating the relation between the HLA -B*4403 allele and lamotrigine
Hye Jung Park, Sung Ryeol Kim, Dong Woo Leem, Il Joo Moon, Beom Seok Koh, Kyung Hee Park, Jung-Won Park, Jae-Hyun Lee
European Journal of Clinical Pharmacology.2015; 71(1): 35.     CrossRef
Stevens-Johnson syndrome and toxic epidermal necrolysis: a 20-year single-center experience
Jovan Lalosevic, Milos Nikolic, Mirjana Gajic-Veljic, Dusan Skiljevic, Ljiljana Medenica
International Journal of Dermatology.2015; 54(8): 978.     CrossRef
Stevens–Johnson syndrome following cataract surgery
Shin-Hua Wu, Jen-Hsiang Shen, Wei-Hsiu Hsu, Chin-Wen Lin, Li-Ju Lai
Taiwan Journal of Ophthalmology.2015; 5(2): 96.     CrossRef
A novel therapeutic strategy for mycoplasma infectious diseases
Kazuhiro Matsuda
Personalized Medicine Universe.2015; 4: 32.     CrossRef
Corticosteroids in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis
Ernest H. Law, May Leung
Annals of Pharmacotherapy.2015; 49(3): 335.     CrossRef
Therapeutic Apheresis in Dermatological Diseases
Rolf Bambauer, Daniel Burgard, Ralf Schiel
Clinical Medicine Insights: Therapeutics.2015; 7: CMT.S14112.     CrossRef
Retrospective Analysis of Corticosteroid Treatment in Stevens-Johnson Syndrome and/or Toxic Epidermal Necrolysis over a Period of 10 Years in Vajira Hospital, Navamindradhiraj University, Bangkok
Wanjarus Roongpisuthipong, Sirikarn Prompongsa, Theerawut Klangjareonchai
Dermatology Research and Practice.2014; 2014: 1.     CrossRef
NSAID Single-Drug–Induced Reactions
Katharine M. Woessner, Mariana Castells
Immunology and Allergy Clinics of North America.2013; 33(2): 237.     CrossRef
Rapidly Developing Toxic Epidermal Necrolysis
Viktoria Oline Barrios Poulsen, Jonas Nielsen, Troels Dirch Poulsen
Case Reports in Emergency Medicine.2013; 2013: 1.     CrossRef
Chronic pulmonary complications due to toxic epidermal necrolysis
Sun Hye Hwang, Dong Hyun Kim, Jeong Hee Kim, Byong Kwan Son, Dae Hyun Lim
Allergy, Asthma & Respiratory Disease.2013; 1(4): 391.     CrossRef
Stevens-Johnson syndrome / toxic epidermal necrolysis: an Asia-Pacific perspective
Bernard Yu-Hor Thong
Asia Pacific Allergy.2013; 3(4): 215.     CrossRef